Delivery Order SPE2DB25D3504-SPE2DB25FVWKY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,237.09 to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (15mL) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Brimonidine Tartrate 0.15% ophthalmic drops, valued at $1,213.60, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger indefinite delivery contract (IDC) vehicle that...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.90 to AmerisourceBergen Drug Corp for Brimonidine-Timolol 0.2%-0.5% ophthalmic solution (10ml), with an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical supply requirements. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,745.53 firm fixed-price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% eye drops in 10 mL bottles. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a $1,470 delivery order to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late September 2023. The firm fixed price contract utilizes no set-aside designations and is issued against an existing DLA-wide supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,256.19 to AmerisourceBergen Drug Corp for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic solution in a 10 milliliter formulation, with completion expected by August 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,901.88 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply brimonidine tartrate 0.15% drops. As the prime contractor, Amerisourcebergen Drug Corp will deliver 15 milliliters of the pharmaceutical product to support DLA medical programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by October 30, 2023. No...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic medication in a 10 mL formulation, with a ceiling value of $73,571.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Brimonidine Tartrate 0.15% eye drops, a medication used to treat increased eye pressure. The contract has a ceiling value of $5,574.52 and a period of performance through January 2, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-nine thousand four hundred forty-eight dollars to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen will deliver five milliliter bottles of the eye drops to a location in Conshohocken, Pennsylvania by August 31, 2023 to support Defense Logistics Agency programs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWKYDelivery Order
The Defense Logistics Agency awarded a $3,193.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company's DLA IDC enables it to supply a comprehensive portfolio of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized medical commodities—to support Defense Health Agency and broader government healthcare systems worldwide. The Brimonidine Tartrate delivery represents routine pharmaceutical fulfillment under this expansive contract vehicle, which positions AmerisourceBergen among the primary vendors for the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/19/25 |